Immediate Impact
32 standout
Citing Papers
Aptamers as an approach to targeted cancer therapy
2024 Standout
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Tarryn Willmer being referenced
Targeting the oncogenic TBX3:nucleolin complex to treat multiple sarcoma subtypes.
2021
Knockdown of Hop downregulates RhoC expression, and decreases pseudopodia formation and migration in cancer cell lines
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Tarryn Willmer | 194 | 23 | 19 | 50 | 47 | 18 | 282 | |
| Haruhiko Hirai | 151 | 21 | 23 | 35 | 51 | 16 | 330 | |
| Yi Yang | 139 | 9 | 26 | 49 | 57 | 19 | 254 | |
| Zhongxia Wang | 168 | 6 | 41 | 39 | 54 | 20 | 289 | |
| Mathew Wallis | 122 | 13 | 9 | 27 | 62 | 18 | 305 | |
| Anne Forand | 180 | 9 | 17 | 29 | 42 | 12 | 317 | |
| Omid Omrani | 142 | 10 | 11 | 34 | 20 | 17 | 253 | |
| C Béraud | 171 | 14 | 12 | 65 | 41 | 22 | 290 | |
| Arístides López‐Márquez | 188 | 16 | 8 | 21 | 36 | 14 | 307 | |
| Zhuoqun Xu | 213 | 21 | 30 | 46 | 64 | 19 | 323 | |
| Binbin Yin | 164 | 23 | 76 | 71 | 79 | 19 | 324 |
All Works
Login with ORCID to disown or claim papers
Loading papers...